InChI=1S/C30H47N3O9S/c1- 2- 3- 12- 15- 24(34) 25(16- 13- 10- 8- 6- 4- 5- 7- 9- 11- 14- 17- 27(36) 37) 43- 21- 23(29(40) 32- 20- 28(38) 39) 33- 26(35) 19- 18- 22(31) 30(41) 42/h4,6- 10,13,16,22- 25,34H,2- 3,5,11- 12,14- 15,17- 21,31H2,1H3,(H,32,40) (H,33,35) (H,36,37) (H,38,39) (H,41,42) /b6- 4- ,9- 7- ,10- 8+,16- 13+/t22- ,23- ,24- ,25+/m0/s1 |
OBQVBASHEWLKCQ-PKBWNXTMSA-N |
CCCCC[C@H](O)[C@H](SC[C@H](NC(=O)CC[C@H](N)C(O)=O)C(=O)NCC(O)=O)\C=C\C=C\C=C/C\C=C/CCCC(O)=O |
|
metabolite
Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
|
|
View more via ChEBI Ontology
L- γ- glutamyl- S- [(6S,7R,8E,10E,12Z,15Z)- 19- carboxy- 6- hydroxynonadeca- 8,10,12,15- tetraen- 7- yl]- L- cysteinylglycine
|
14,15-Leukotriene C4
|
SUBMITTER
|
14,15-LTC4
|
SUBMITTER
|
15S-hydroxy,14R-(S-glutathionyl)-5Z,8Z,10E,12E-eicosatetraenoic acid
|
LIPID MAPS
|
EXC4
|
SUBMITTER
|
19521975
|
Reaxys Registry Number
|
Reaxys
|
18184802
|
PubMed citation
|
Europe PMC
|
19438588
|
PubMed citation
|
Europe PMC
|
|